|
Development and Approval of Drugs and Devices
EPI 260 Spring 2012 (1.5 units)
This course will provide a survey of drug and device development from late preclinical through phase 3 clinical studies. Through lectures and case studies, it will introduce students to drug/device regulations, investigational new drug filings, assessment of drug candidates, statistics, safety monitoring, clinical study design and conduct. At the end of the course, students will be able to:
None.
Lectures: Wednesdays, 10:30 AM to 12 PM, March 28 through May 30. Principles and Practice of Clinical Trial Medicine by Richard Chin and Bruce Y Lee. Academic Press. 1st Edition. 2008. Books may be purchased either through the publisher or a variety of commercial venues (e.g., Amazon.com). 50% of the grade will be based on the case study assignment and 50% on the homework assignments. Homework assignments are due the week following the week they are assigned. The case study assignment is due May 30. How to turn in your homework assignment:
This course is open to a limited number of individuals outside of the ATCR and Master's programs. Preference is given to UCSF-affiliated personnel. We regret that auditing is not permitted. To apply for this course please fill out and submit the application below. Cost and submission information are in the application. Note: CTSI tuition scholarships are available for UCSF Graduate Students pursuing a PhD degree in one of the laboratory-based basic science programs and UCSF post-doctoral (PhD) fellows working in a basic science laboratory. Application (Word doc, 20KB) |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||